Safety and Efficacy of HO/02/02 20µg vs. SoC (Aloe Vera) to Reduce Radiation Dermatitis
Status:
Unknown status
Trial end date:
2014-12-01
Target enrollment:
Participant gender:
Summary
This is a single-center, open-label, randomized, prospective study evaluating the safety and
efficacy of HO/02/02 20µg topically applied daily for 15 minutes (with gauze) on treatment
fields vs. standard of care (SoC), Aloe Vera treatment